{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:36:42Z","timestamp":1761709002256,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.canrad.2014.06.015","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T07:34:37Z","timestamp":1410852877000},"page":"425-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Indications non oncologiques de la radioth\u00e9rapie\u00a0: quelles indications en 2014\u00a0?"],"prefix":"10.1016","volume":"18","author":[{"given":"P.","family":"Van Houtte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roelandts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.06.015_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.canrad.2005.09.004","article-title":"La radioth\u00e9rapie des affections b\u00e9nignes\u00a0: quelles indications huit ans plus tard\u00a0?","volume":"9","author":"Van Houtte","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2007.04.008","article-title":"Radiotherapy of non-malignant disorders: where do we stand?","volume":"83","author":"Leer","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-8140(98)00051-6","article-title":"Indications and treatment schedules for irradiation of benign diseases: a survey","volume":"48","author":"Leer","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0020","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1278-3218(01)00136-6","article-title":"Affections b\u00e9nignes et radioth\u00e9rapie\u00a0: une enqu\u00eate de la pratique en Belgique. Peer Review de radioth\u00e9rapie de Belgique","volume":"5","author":"Beauduin","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0360-3016(99)00537-4","article-title":"Radiation therapy for benign diseases: a pattern of care study in Germany","volume":"47","author":"Seegenschmiedt","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"year":"1998","series-title":"Radiation therapy of benign diseases: a clinical guide","author":"Order","key":"10.1016\/j.canrad.2014.06.015_bib0030"},{"year":"2008","series-title":"Radiotherapy for non malignant disorders. Contemporary concepts and clinical results","author":"Seegenschmiedt","key":"10.1016\/j.canrad.2014.06.015_bib0035"},{"key":"10.1016\/j.canrad.2014.06.015_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canrad.2010.03.020","article-title":"The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions","volume":"15","author":"Ali","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2003.12.021","article-title":"Prevention of Pterygium recurrence by postoperative single dose B-irradiation: a prospective randomised clinical double-blind trial","volume":"59","author":"J\u00fcrgenliemk-Schulz","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0050","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophtalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophtalmology"},{"key":"10.1016\/j.canrad.2014.06.015_bib0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves\u2019 orbitopathy: randomised placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2014.06.015_bib0060","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomized double-blind trial of prednisone versus radiotherapy in Graves\u2019 ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2014.06.015_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A randomised controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves ophtalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.canrad.2014.06.015_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)03795-1","article-title":"Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16Gy","volume":"55","author":"Gerling","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0075","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves\u2019 ophtalmopathy: is it safe? A long-term follow-up study","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophtalmology"},{"key":"10.1016\/j.canrad.2014.06.015_bib0080","first-page":"CD007114","article-title":"Orbital radiotherapy for adult thyroid eye disease","volume":"7","author":"Rajendram","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2014.06.015_bib0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9394(02)01821-4","article-title":"Proton therapy for exudative age-related macular degeneration: a randomised sham controlled clinical trial","volume":"134","author":"Ciulla","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2004.11.029","article-title":"Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized trial","volume":"112","author":"Jaakkola","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canrad.2014.06.015_bib0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2012.07.2352","article-title":"Radiation therapy for neovascular age-related macular degeneration","volume":"85","author":"Kishan","year":"2013","journal-title":"Int J Radiat Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0100","first-page":"CD001001","article-title":"Radiotherapy for neovascular age-related macular degeneration","volume":"4","author":"Sivagnanavel","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2014.06.015_bib0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(02)01336-3","article-title":"Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial","volume":"133","author":"Valmaggia","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0110","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ophtha.2013.02.016","article-title":"Stereotactic radiotherapy for neovascular age-related macular degenration: 52weeks safety and efficacy results of the INTREPID study","volume":"120","author":"Jackson","year":"2013","journal-title":"Ophtalmology"},{"key":"10.1016\/j.canrad.2014.06.015_bib0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00003086-197105000-00030","article-title":"Osteogenesis by radioisotope labelled cell populations in implants of bone matrix under the influence of ionizing radiation","volume":"76","author":"Craven","year":"1971","journal-title":"Clin Orthop"},{"key":"10.1016\/j.canrad.2014.06.015_bib0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(94)90519-3","article-title":"Randomized trial comparing preoperative versus post-operative irradiation for prevention of heterotopic ossification following prosthetic hip replacement: preliminary results","volume":"30","author":"Gregoritch","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-8140(93)90270-I","article-title":"Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy","volume":"26","author":"Seegenschmiedt","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0360-3016(94)90520-7","article-title":"Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients","volume":"30","author":"Seegenschmiedt","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canrad.2010.10.003","article-title":"Postoperative radiation therapy after hip replacement in high-risk patients for development of heterotopic bone formation","volume":"15","author":"Hashem","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.arth.2013.06.039","article-title":"Celcoxib and heterotopic bone formation after total hip arthroplasty","volume":"29","author":"Lavernia","year":"2014","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.canrad.2014.06.015_bib0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2003.11.015","article-title":"Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomised trials","volume":"60","author":"Pakos","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0150","first-page":"CD0011160","article-title":"Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty","volume":"3","author":"Fransen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2014.06.015_bib0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0360-3016(03)01620-1","article-title":"Radiotherapy in painful heel spurs (plantar ascitis). Results of a national pattern of care study","volume":"58","author":"Micke","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijrobp.2012.06.022","article-title":"Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12months\u2019 follow-up","volume":"84","author":"Niewald","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0165","first-page":"311","article-title":"Evaluation of radiation treatment of painful conditions of the locomotor","volume":"9","author":"Goldie","year":"1970","journal-title":"Acta Radiol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00066-013-0504-1","article-title":"The Erlangen dose optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results","volume":"190","author":"Ott","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0175","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00066-012-0170-8","article-title":"Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved","volume":"11","author":"Arenas","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009747809095660","article-title":"Comparison of chemical, radiation and surgical synovectomy for knee joint synovitis","volume":"7","author":"Nissil\u00e4","year":"1978","journal-title":"Scand J Theumatol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/03009748109095304","article-title":"Osmic acid versus yttrium-90 in rheumatoid synovitis of the knee","volume":"10","author":"Sheppeard","year":"1981","journal-title":"Scand J Theumatol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-010-1626-9","article-title":"Effectiveness of radiation synovectomy with Yttrium-90 and Samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, randomized, double-blinded trial","volume":"30","author":"Dos Santos","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0195","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2516.2012.02908.x","article-title":"Opinions on radiosynovectomy for chronic haemophilic synovitis: point\/counterpoint","volume":"18","author":"Silva","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.canrad.2014.06.015_bib0200","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.canrad.2014.06.015_bib0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000245986","article-title":"Post-operative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 scars","volume":"195","author":"Clav\u00e8re","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.canrad.2014.06.015_bib0210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0360-3016(88)90119-8","article-title":"The role of ionising irradiation for 393 keloids","volume":"15","author":"Borok","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0215","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0360-3016(90)90405-9","article-title":"The role of kilovoltage irradiation in the treatment of keloids","volume":"18","author":"Doornbos","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canrad.2012.11.002","article-title":"Traitement postop\u00e9ratoire des cicatrices ch\u00e9lo\u00efdes\u00a0: \u00e9lectrons ou irradiation interstitielle","volume":"17","author":"Yossi","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0360-3016(93)90204-9","article-title":"The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision","volume":"26","author":"Escarmant","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(00)01563-7","article-title":"Treatment of keloids by high-dose-rate brachytherapy: a seven-year study","volume":"50","author":"Guix","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0235","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ijrobp.2009.12.019","article-title":"A radiobiological analysis of multicenter data for postoperative keloid radiotherapy","volume":"79","author":"Flickinger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000316381","article-title":"Surgical excision and immediate postoperative radiotherapy versus cryotherapy and intralesional steroids in the management of keloids: a prospective clinical trial","volume":"19","author":"Emad","year":"2010","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.canrad.2014.06.015_bib0245","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.sap.0000237761.52586.f9","article-title":"Is the treatment of keloid scar still a challenge in 2006?","volume":"58","author":"Lorenzi","year":"2007","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.canrad.2014.06.015_bib0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00066-010-2063-z","article-title":"Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13years","volume":"186","author":"Betz","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.06.015_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1278-3218(00)00051-2","article-title":"La synovite villonodulaire pigment\u00e9e\u00a0: \u00e0 propos de 3\u00a0cas","volume":"5","author":"Gouders","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.06.015_bib0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0360-3016(95)00514-Y","article-title":"Outcome following radiation treatment for high-risk pigmented villonodular synovitis","volume":"66","author":"O'Sullivan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.06.015_bib0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00365596909135402","article-title":"Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinomas","volume":"3","author":"Alafthan","year":"1969","journal-title":"Scand J Urol Nephrol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321814001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321814001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:25:46Z","timestamp":1761135946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321814001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":53,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1278321814001589"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.06.015","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications non oncologiques de la radioth\u00e9rapie\u00a0: quelles indications en 2014\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}